![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JB Monahan, WF Hood, J Michel and RP Compton
Searle Research and Development, Division of G.D. Searle & Co., St. Louis, Missouri 63198.
Guanine nucleotides have been examined as to their effects on subclass- specific excitatory amino acid receptor-ligand interactions. Guanine nucleotides selectively inhibit L-[3H]glutamate binding to the N-methyl- D-aspartate (NMDA) recognition site while showing a lesser effect on [3H]kainate, [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate and sodium-dependent L-[3H]glutamate binding. Of the series of guanine nucleotides tested in the inhibition of NMDA-specific L-[3H]glutamate binding, GTP, GDP, 5'-guanylylimidodiphosphate and 5'- guanylylmethylenediphosphate were significantly more potent than GMP, cyclic GMP and guanosine. Scatchard analysis indicates that the GTP inhibition (IC50 = 28 microM) of this NMDA-specific L-[3H]glutamate binding results from a decrease in the affinity of L-glutamate for the NMDA receptor whereas no alteration in the number of binding sites is observed. A kinetic analysis indicates that this decrease in affinity may be attributed to a decrease in association rate whereas no change in dissociation rate is observed. GTP (25 microM) lowers the affinities of both NMDA agonists (NMDA, L-glutamate, L-aspartate, and L- homocysteate) and antagonists (D-2-amino-5-phosphonovalerate, D-2-amino- 7-phosphonoheptanoate, and D-2-aminoadipate). Pretreatment of the synaptic plasma membranes with either pertussis or cholera toxin had no significant effect on the GTP inhibition of NMDA-specific L-[3H] glutamate binding. The data suggest that guanine nucleotides can negatively modulate the NMDA receptor; however, the mechanism of this modulation is unclear.
This article has been cited by other articles:
|
|
 |
|
  E. Suzuki, M. Kessler, K. Montgomery, and A. C. Arai Divergent Effects of the Purinoceptor Antagonists Suramin and Pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Mol. Pharmacol., December 1, 2004; 66(6): 1738 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kloda, J. D. Clements, R. J. Lewis, and D. J. Adams Adenosine Triphosphate Acts as Both a Competitive Antagonist and a Positive Allosteric Modulator at Recombinant N-Methyl-D-aspartate Receptors Mol. Pharmacol., June 1, 2004; 65(6): 1386 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Burgos, J. Aleu, A. Barat, C. Solsona, J. Marsal, and G. Ramirez Kainate-Triggered Currents in Xenopus Oocytes Injected with Chick Retinal Membrane Fragments: Effect of Guanine Nucleotides Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3124 - 3129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ortinau, B. Laube, and H. Zimmermann ATP Inhibits NMDA Receptors after Heterologous Expression and in Cultured Hippocampal Neurons and Attenuates NMDA-Mediated Neurotoxicity J. Neurosci., June 15, 2003; 23(12): 4996 - 5003. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
